nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—CYP2D6—Hydroxyurea—head and neck cancer	0.152	0.271	CbGbCtD
Clomipramine—ALB—Fluorouracil—head and neck cancer	0.118	0.21	CbGbCtD
Clomipramine—CYP1A2—Fluorouracil—head and neck cancer	0.0705	0.126	CbGbCtD
Clomipramine—ABCB1—Vinblastine—head and neck cancer	0.0572	0.102	CbGbCtD
Clomipramine—CYP2D6—Vinblastine—head and neck cancer	0.0538	0.096	CbGbCtD
Clomipramine—ABCB1—Docetaxel—head and neck cancer	0.0471	0.084	CbGbCtD
Clomipramine—CYP3A4—Vinblastine—head and neck cancer	0.0342	0.061	CbGbCtD
Clomipramine—CYP3A4—Docetaxel—head and neck cancer	0.0282	0.0503	CbGbCtD
Clomipramine—HTR2A—trigeminal nerve—head and neck cancer	0.00185	0.0956	CbGeAlD
Clomipramine—Breast disorder—Hydroxyurea—head and neck cancer	0.00158	0.00497	CcSEcCtD
Clomipramine—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00158	0.00496	CcSEcCtD
Clomipramine—Pancytopenia—Vinblastine—head and neck cancer	0.00158	0.00495	CcSEcCtD
Clomipramine—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00156	0.0049	CcSEcCtD
Clomipramine—Ageusia—Docetaxel—head and neck cancer	0.00155	0.00486	CcSEcCtD
Clomipramine—Euphoric mood—Fluorouracil—head and neck cancer	0.00149	0.00469	CcSEcCtD
Clomipramine—Depression—Vinblastine—head and neck cancer	0.00148	0.00464	CcSEcCtD
Clomipramine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00146	0.00459	CcSEcCtD
Clomipramine—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00146	0.00458	CcSEcCtD
Clomipramine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00145	0.00456	CcSEcCtD
Clomipramine—Myocardial infarction—Vinblastine—head and neck cancer	0.00145	0.00456	CcSEcCtD
Clomipramine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00144	0.00452	CcSEcCtD
Clomipramine—Photosensitivity—Fluorouracil—head and neck cancer	0.00144	0.00451	CcSEcCtD
Clomipramine—Amenorrhoea—Docetaxel—head and neck cancer	0.00143	0.00448	CcSEcCtD
Clomipramine—Dysuria—Hydroxyurea—head and neck cancer	0.00142	0.00445	CcSEcCtD
Clomipramine—Disorientation—Fluorouracil—head and neck cancer	0.00141	0.00443	CcSEcCtD
Clomipramine—Agranulocytosis—Vinblastine—head and neck cancer	0.00138	0.00434	CcSEcCtD
Clomipramine—Weight increased—Hydroxyurea—head and neck cancer	0.00138	0.00433	CcSEcCtD
Clomipramine—Oliguria—Docetaxel—head and neck cancer	0.00136	0.00427	CcSEcCtD
Clomipramine—Drowsiness—Hydroxyurea—head and neck cancer	0.00135	0.00424	CcSEcCtD
Clomipramine—GSTP1—exocrine gland—head and neck cancer	0.00135	0.0697	CbGeAlD
Clomipramine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00132	0.00416	CcSEcCtD
Clomipramine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00132	0.00415	CcSEcCtD
Clomipramine—HTR2A—cranial nerve—head and neck cancer	0.00132	0.0681	CbGeAlD
Clomipramine—Pharyngitis—Vinblastine—head and neck cancer	0.00132	0.00414	CcSEcCtD
Clomipramine—Cardiac failure—Fluorouracil—head and neck cancer	0.00129	0.00406	CcSEcCtD
Clomipramine—GSTP1—hair follicle—head and neck cancer	0.00129	0.0664	CbGeAlD
Clomipramine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00128	0.00401	CcSEcCtD
Clomipramine—Respiratory failure—Docetaxel—head and neck cancer	0.00128	0.00401	CcSEcCtD
Clomipramine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00126	0.00396	CcSEcCtD
Clomipramine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00126	0.00396	CcSEcCtD
Clomipramine—Blood pressure increased—Docetaxel—head and neck cancer	0.00125	0.00394	CcSEcCtD
Clomipramine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00125	0.00394	CcSEcCtD
Clomipramine—Hallucination—Hydroxyurea—head and neck cancer	0.00121	0.00379	CcSEcCtD
Clomipramine—Colitis—Docetaxel—head and neck cancer	0.0012	0.00378	CcSEcCtD
Clomipramine—Irritability—Fluorouracil—head and neck cancer	0.0012	0.00378	CcSEcCtD
Clomipramine—Cardiac arrest—Fluorouracil—head and neck cancer	0.0012	0.00377	CcSEcCtD
Clomipramine—Ataxia—Fluorouracil—head and neck cancer	0.00119	0.00373	CcSEcCtD
Clomipramine—Neuropathy—Docetaxel—head and neck cancer	0.00118	0.0037	CcSEcCtD
Clomipramine—Alopecia—Vinblastine—head and neck cancer	0.00117	0.00369	CcSEcCtD
Clomipramine—Dry skin—Fluorouracil—head and neck cancer	0.00116	0.00363	CcSEcCtD
Clomipramine—Oesophagitis—Docetaxel—head and neck cancer	0.00115	0.0036	CcSEcCtD
Clomipramine—Muscular weakness—Fluorouracil—head and neck cancer	0.00111	0.00349	CcSEcCtD
Clomipramine—Angiopathy—Hydroxyurea—head and neck cancer	0.0011	0.00346	CcSEcCtD
Clomipramine—Dysphagia—Fluorouracil—head and neck cancer	0.00109	0.00342	CcSEcCtD
Clomipramine—Chills—Hydroxyurea—head and neck cancer	0.00109	0.00342	CcSEcCtD
Clomipramine—Eosinophilia—Fluorouracil—head and neck cancer	0.00108	0.00339	CcSEcCtD
Clomipramine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00107	0.00337	CcSEcCtD
Clomipramine—Alopecia—Hydroxyurea—head and neck cancer	0.00107	0.00337	CcSEcCtD
Clomipramine—Anaemia—Vinblastine—head and neck cancer	0.00107	0.00336	CcSEcCtD
Clomipramine—Thrombophlebitis—Docetaxel—head and neck cancer	0.00105	0.0033	CcSEcCtD
Clomipramine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00105	0.00329	CcSEcCtD
Clomipramine—Malaise—Vinblastine—head and neck cancer	0.00104	0.00328	CcSEcCtD
Clomipramine—Vertigo—Vinblastine—head and neck cancer	0.00104	0.00327	CcSEcCtD
Clomipramine—Leukopenia—Vinblastine—head and neck cancer	0.00104	0.00325	CcSEcCtD
Clomipramine—Pancytopenia—Fluorouracil—head and neck cancer	0.00104	0.00325	CcSEcCtD
Clomipramine—Deafness—Docetaxel—head and neck cancer	0.00102	0.0032	CcSEcCtD
Clomipramine—GSTP1—mouth—head and neck cancer	0.00101	0.0521	CbGeAlD
Clomipramine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.001	0.00315	CcSEcCtD
Clomipramine—Convulsion—Vinblastine—head and neck cancer	0.001	0.00315	CcSEcCtD
Clomipramine—Hypertension—Vinblastine—head and neck cancer	0.000999	0.00314	CcSEcCtD
Clomipramine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000995	0.00313	CcSEcCtD
Clomipramine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000979	0.00308	CcSEcCtD
Clomipramine—Pneumonia—Fluorouracil—head and neck cancer	0.000977	0.00307	CcSEcCtD
Clomipramine—Anaemia—Hydroxyurea—head and neck cancer	0.000975	0.00306	CcSEcCtD
Clomipramine—Discomfort—Vinblastine—head and neck cancer	0.000973	0.00306	CcSEcCtD
Clomipramine—Hot flush—Docetaxel—head and neck cancer	0.000973	0.00306	CcSEcCtD
Clomipramine—Menopausal symptoms—Docetaxel—head and neck cancer	0.000965	0.00303	CcSEcCtD
Clomipramine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000958	0.00301	CcSEcCtD
Clomipramine—Myocardial infarction—Fluorouracil—head and neck cancer	0.000953	0.00299	CcSEcCtD
Clomipramine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000953	0.00299	CcSEcCtD
Clomipramine—Malaise—Hydroxyurea—head and neck cancer	0.000951	0.00299	CcSEcCtD
Clomipramine—Conjunctivitis—Fluorouracil—head and neck cancer	0.000945	0.00297	CcSEcCtD
Clomipramine—Urinary tract infection—Fluorouracil—head and neck cancer	0.000945	0.00297	CcSEcCtD
Clomipramine—Leukopenia—Hydroxyurea—head and neck cancer	0.000944	0.00297	CcSEcCtD
Clomipramine—Cardiac failure—Docetaxel—head and neck cancer	0.000933	0.00293	CcSEcCtD
Clomipramine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000924	0.0029	CcSEcCtD
Clomipramine—Epistaxis—Fluorouracil—head and neck cancer	0.000917	0.00288	CcSEcCtD
Clomipramine—Convulsion—Hydroxyurea—head and neck cancer	0.000914	0.00287	CcSEcCtD
Clomipramine—Sinusitis—Fluorouracil—head and neck cancer	0.000912	0.00286	CcSEcCtD
Clomipramine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00091	0.00286	CcSEcCtD
Clomipramine—Agranulocytosis—Fluorouracil—head and neck cancer	0.000907	0.00285	CcSEcCtD
Clomipramine—Anorexia—Vinblastine—head and neck cancer	0.0009	0.00283	CcSEcCtD
Clomipramine—Migraine—Docetaxel—head and neck cancer	0.000896	0.00281	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000892	0.0028	CcSEcCtD
Clomipramine—Discomfort—Hydroxyurea—head and neck cancer	0.000887	0.00279	CcSEcCtD
Clomipramine—Rhinitis—Fluorouracil—head and neck cancer	0.000875	0.00275	CcSEcCtD
Clomipramine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000868	0.00273	CcSEcCtD
Clomipramine—Pharyngitis—Fluorouracil—head and neck cancer	0.000866	0.00272	CcSEcCtD
Clomipramine—GSTP1—neck—head and neck cancer	0.000863	0.0446	CbGeAlD
Clomipramine—Oedema—Hydroxyurea—head and neck cancer	0.000861	0.00271	CcSEcCtD
Clomipramine—Ataxia—Docetaxel—head and neck cancer	0.000856	0.00269	CcSEcCtD
Clomipramine—Paraesthesia—Vinblastine—head and neck cancer	0.000848	0.00266	CcSEcCtD
Clomipramine—Dehydration—Docetaxel—head and neck cancer	0.000846	0.00266	CcSEcCtD
Clomipramine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000844	0.00265	CcSEcCtD
Clomipramine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000843	0.00265	CcSEcCtD
Clomipramine—Skin disorder—Hydroxyurea—head and neck cancer	0.000836	0.00263	CcSEcCtD
Clomipramine—Dry skin—Docetaxel—head and neck cancer	0.000834	0.00262	CcSEcCtD
Clomipramine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000831	0.00261	CcSEcCtD
Clomipramine—Breast disorder—Docetaxel—head and neck cancer	0.000823	0.00258	CcSEcCtD
Clomipramine—Anorexia—Hydroxyurea—head and neck cancer	0.000821	0.00258	CcSEcCtD
Clomipramine—Decreased appetite—Vinblastine—head and neck cancer	0.000821	0.00258	CcSEcCtD
Clomipramine—Pain—Vinblastine—head and neck cancer	0.000807	0.00254	CcSEcCtD
Clomipramine—Constipation—Vinblastine—head and neck cancer	0.000807	0.00254	CcSEcCtD
Clomipramine—Dysphagia—Docetaxel—head and neck cancer	0.000787	0.00247	CcSEcCtD
Clomipramine—Arrhythmia—Fluorouracil—head and neck cancer	0.000779	0.00245	CcSEcCtD
Clomipramine—Feeling abnormal—Vinblastine—head and neck cancer	0.000778	0.00244	CcSEcCtD
Clomipramine—Bronchospasm—Docetaxel—head and neck cancer	0.000774	0.00243	CcSEcCtD
Clomipramine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000772	0.00243	CcSEcCtD
Clomipramine—Alopecia—Fluorouracil—head and neck cancer	0.000771	0.00242	CcSEcCtD
Clomipramine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000768	0.00241	CcSEcCtD
Clomipramine—Somnolence—Hydroxyurea—head and neck cancer	0.000766	0.00241	CcSEcCtD
Clomipramine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000758	0.00238	CcSEcCtD
Clomipramine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000749	0.00235	CcSEcCtD
Clomipramine—Pancytopenia—Docetaxel—head and neck cancer	0.000747	0.00235	CcSEcCtD
Clomipramine—Abdominal pain—Vinblastine—head and neck cancer	0.000746	0.00235	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000743	0.00234	CcSEcCtD
Clomipramine—Fatigue—Hydroxyurea—head and neck cancer	0.000742	0.00233	CcSEcCtD
Clomipramine—Constipation—Hydroxyurea—head and neck cancer	0.000736	0.00231	CcSEcCtD
Clomipramine—Pain—Hydroxyurea—head and neck cancer	0.000736	0.00231	CcSEcCtD
Clomipramine—Weight increased—Docetaxel—head and neck cancer	0.000716	0.00225	CcSEcCtD
Clomipramine—Vision blurred—Fluorouracil—head and neck cancer	0.000716	0.00225	CcSEcCtD
Clomipramine—Weight decreased—Docetaxel—head and neck cancer	0.000712	0.00224	CcSEcCtD
Clomipramine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00071	0.00223	CcSEcCtD
Clomipramine—Pneumonia—Docetaxel—head and neck cancer	0.000705	0.00222	CcSEcCtD
Clomipramine—GSTP1—parotid gland—head and neck cancer	0.000703	0.0363	CbGeAlD
Clomipramine—Anaemia—Fluorouracil—head and neck cancer	0.000702	0.00221	CcSEcCtD
Clomipramine—Hypersensitivity—Vinblastine—head and neck cancer	0.000696	0.00219	CcSEcCtD
Clomipramine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000691	0.00217	CcSEcCtD
Clomipramine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000688	0.00216	CcSEcCtD
Clomipramine—Myocardial infarction—Docetaxel—head and neck cancer	0.000688	0.00216	CcSEcCtD
Clomipramine—Jaundice—Docetaxel—head and neck cancer	0.000684	0.00215	CcSEcCtD
Clomipramine—Conjunctivitis—Docetaxel—head and neck cancer	0.000682	0.00214	CcSEcCtD
Clomipramine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000681	0.00214	CcSEcCtD
Clomipramine—Leukopenia—Fluorouracil—head and neck cancer	0.00068	0.00214	CcSEcCtD
Clomipramine—Asthenia—Vinblastine—head and neck cancer	0.000677	0.00213	CcSEcCtD
Clomipramine—GSTP1—saliva-secreting gland—head and neck cancer	0.000673	0.0348	CbGeAlD
Clomipramine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000663	0.00208	CcSEcCtD
Clomipramine—Epistaxis—Docetaxel—head and neck cancer	0.000662	0.00208	CcSEcCtD
Clomipramine—Convulsion—Fluorouracil—head and neck cancer	0.000658	0.00207	CcSEcCtD
Clomipramine—Agranulocytosis—Docetaxel—head and neck cancer	0.000655	0.00206	CcSEcCtD
Clomipramine—Myalgia—Fluorouracil—head and neck cancer	0.000647	0.00203	CcSEcCtD
Clomipramine—Chest pain—Fluorouracil—head and neck cancer	0.000647	0.00203	CcSEcCtD
Clomipramine—Diarrhoea—Vinblastine—head and neck cancer	0.000646	0.00203	CcSEcCtD
Clomipramine—Discomfort—Fluorouracil—head and neck cancer	0.000639	0.00201	CcSEcCtD
Clomipramine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000634	0.00199	CcSEcCtD
Clomipramine—Rhinitis—Docetaxel—head and neck cancer	0.000631	0.00198	CcSEcCtD
Clomipramine—Hepatitis—Docetaxel—head and neck cancer	0.00063	0.00198	CcSEcCtD
Clomipramine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000627	0.00197	CcSEcCtD
Clomipramine—Confusional state—Fluorouracil—head and neck cancer	0.000625	0.00196	CcSEcCtD
Clomipramine—Pharyngitis—Docetaxel—head and neck cancer	0.000625	0.00196	CcSEcCtD
Clomipramine—Dizziness—Vinblastine—head and neck cancer	0.000624	0.00196	CcSEcCtD
Clomipramine—Urinary tract disorder—Docetaxel—head and neck cancer	0.000622	0.00195	CcSEcCtD
Clomipramine—Oedema—Fluorouracil—head and neck cancer	0.00062	0.00195	CcSEcCtD
Clomipramine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00062	0.00195	CcSEcCtD
Clomipramine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000619	0.00194	CcSEcCtD
Clomipramine—GSTP1—connective tissue—head and neck cancer	0.000618	0.0319	CbGeAlD
Clomipramine—Asthenia—Hydroxyurea—head and neck cancer	0.000618	0.00194	CcSEcCtD
Clomipramine—Urethral disorder—Docetaxel—head and neck cancer	0.000617	0.00194	CcSEcCtD
Clomipramine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000608	0.00191	CcSEcCtD
Clomipramine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000607	0.00191	CcSEcCtD
Clomipramine—Visual impairment—Docetaxel—head and neck cancer	0.000607	0.00191	CcSEcCtD
Clomipramine—Tachycardia—Fluorouracil—head and neck cancer	0.000605	0.0019	CcSEcCtD
Clomipramine—Vomiting—Vinblastine—head and neck cancer	0.0006	0.00189	CcSEcCtD
Clomipramine—Headache—Vinblastine—head and neck cancer	0.000592	0.00186	CcSEcCtD
Clomipramine—Anorexia—Fluorouracil—head and neck cancer	0.000591	0.00186	CcSEcCtD
Clomipramine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000589	0.00185	CcSEcCtD
Clomipramine—Eye disorder—Docetaxel—head and neck cancer	0.000588	0.00185	CcSEcCtD
Clomipramine—GSTP1—epithelium—head and neck cancer	0.000587	0.0303	CbGeAlD
Clomipramine—Flushing—Docetaxel—head and neck cancer	0.000584	0.00184	CcSEcCtD
Clomipramine—Cardiac disorder—Docetaxel—head and neck cancer	0.000584	0.00184	CcSEcCtD
Clomipramine—Hypotension—Fluorouracil—head and neck cancer	0.000579	0.00182	CcSEcCtD
Clomipramine—Angiopathy—Docetaxel—head and neck cancer	0.000571	0.00179	CcSEcCtD
Clomipramine—Dizziness—Hydroxyurea—head and neck cancer	0.000569	0.00179	CcSEcCtD
Clomipramine—Immune system disorder—Docetaxel—head and neck cancer	0.000569	0.00179	CcSEcCtD
Clomipramine—Mediastinal disorder—Docetaxel—head and neck cancer	0.000567	0.00178	CcSEcCtD
Clomipramine—Chills—Docetaxel—head and neck cancer	0.000565	0.00178	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000565	0.00177	CcSEcCtD
Clomipramine—Arrhythmia—Docetaxel—head and neck cancer	0.000563	0.00177	CcSEcCtD
Clomipramine—Nausea—Vinblastine—head and neck cancer	0.000561	0.00176	CcSEcCtD
Clomipramine—Insomnia—Fluorouracil—head and neck cancer	0.000561	0.00176	CcSEcCtD
Clomipramine—Paraesthesia—Fluorouracil—head and neck cancer	0.000557	0.00175	CcSEcCtD
Clomipramine—Alopecia—Docetaxel—head and neck cancer	0.000556	0.00175	CcSEcCtD
Clomipramine—HTR6—head—head and neck cancer	0.000554	0.0286	CbGeAlD
Clomipramine—Dyspnoea—Fluorouracil—head and neck cancer	0.000553	0.00174	CcSEcCtD
Clomipramine—Mental disorder—Docetaxel—head and neck cancer	0.000552	0.00173	CcSEcCtD
Clomipramine—Somnolence—Fluorouracil—head and neck cancer	0.000551	0.00173	CcSEcCtD
Clomipramine—Malnutrition—Docetaxel—head and neck cancer	0.000548	0.00172	CcSEcCtD
Clomipramine—Vomiting—Hydroxyurea—head and neck cancer	0.000547	0.00172	CcSEcCtD
Clomipramine—Dyspepsia—Fluorouracil—head and neck cancer	0.000546	0.00171	CcSEcCtD
Clomipramine—Rash—Hydroxyurea—head and neck cancer	0.000543	0.00171	CcSEcCtD
Clomipramine—Dermatitis—Hydroxyurea—head and neck cancer	0.000542	0.0017	CcSEcCtD
Clomipramine—Headache—Hydroxyurea—head and neck cancer	0.000539	0.00169	CcSEcCtD
Clomipramine—Decreased appetite—Fluorouracil—head and neck cancer	0.000539	0.00169	CcSEcCtD
Clomipramine—Dysgeusia—Docetaxel—head and neck cancer	0.000537	0.00169	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000535	0.00168	CcSEcCtD
Clomipramine—Back pain—Docetaxel—head and neck cancer	0.00053	0.00167	CcSEcCtD
Clomipramine—Pain—Fluorouracil—head and neck cancer	0.00053	0.00167	CcSEcCtD
Clomipramine—Muscle spasms—Docetaxel—head and neck cancer	0.000527	0.00166	CcSEcCtD
Clomipramine—GSTP1—trachea—head and neck cancer	0.000519	0.0268	CbGeAlD
Clomipramine—Nausea—Hydroxyurea—head and neck cancer	0.000511	0.00161	CcSEcCtD
Clomipramine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000511	0.0016	CcSEcCtD
Clomipramine—Anaemia—Docetaxel—head and neck cancer	0.000507	0.00159	CcSEcCtD
Clomipramine—HRH2—head—head and neck cancer	0.000506	0.0261	CbGeAlD
Clomipramine—Urticaria—Fluorouracil—head and neck cancer	0.000492	0.00155	CcSEcCtD
Clomipramine—Syncope—Docetaxel—head and neck cancer	0.000492	0.00154	CcSEcCtD
Clomipramine—Leukopenia—Docetaxel—head and neck cancer	0.000491	0.00154	CcSEcCtD
Clomipramine—Body temperature increased—Fluorouracil—head and neck cancer	0.00049	0.00154	CcSEcCtD
Clomipramine—Palpitations—Docetaxel—head and neck cancer	0.000484	0.00152	CcSEcCtD
Clomipramine—Loss of consciousness—Docetaxel—head and neck cancer	0.000482	0.00151	CcSEcCtD
Clomipramine—Cough—Docetaxel—head and neck cancer	0.000478	0.0015	CcSEcCtD
Clomipramine—Convulsion—Docetaxel—head and neck cancer	0.000475	0.00149	CcSEcCtD
Clomipramine—Hypertension—Docetaxel—head and neck cancer	0.000473	0.00149	CcSEcCtD
Clomipramine—Myalgia—Docetaxel—head and neck cancer	0.000467	0.00147	CcSEcCtD
Clomipramine—Chest pain—Docetaxel—head and neck cancer	0.000467	0.00147	CcSEcCtD
Clomipramine—Arthralgia—Docetaxel—head and neck cancer	0.000467	0.00147	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000463	0.00146	CcSEcCtD
Clomipramine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000457	0.00143	CcSEcCtD
Clomipramine—Dry mouth—Docetaxel—head and neck cancer	0.000456	0.00143	CcSEcCtD
Clomipramine—GSTP1—lymphoid tissue—head and neck cancer	0.000452	0.0233	CbGeAlD
Clomipramine—Confusional state—Docetaxel—head and neck cancer	0.000451	0.00142	CcSEcCtD
Clomipramine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000447	0.00141	CcSEcCtD
Clomipramine—Oedema—Docetaxel—head and neck cancer	0.000447	0.00141	CcSEcCtD
Clomipramine—Shock—Docetaxel—head and neck cancer	0.00044	0.00138	CcSEcCtD
Clomipramine—Nervous system disorder—Docetaxel—head and neck cancer	0.000439	0.00138	CcSEcCtD
Clomipramine—Pruritus—Fluorouracil—head and neck cancer	0.000439	0.00138	CcSEcCtD
Clomipramine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000438	0.00138	CcSEcCtD
Clomipramine—Tachycardia—Docetaxel—head and neck cancer	0.000437	0.00137	CcSEcCtD
Clomipramine—Skin disorder—Docetaxel—head and neck cancer	0.000435	0.00137	CcSEcCtD
Clomipramine—Anorexia—Docetaxel—head and neck cancer	0.000426	0.00134	CcSEcCtD
Clomipramine—Diarrhoea—Fluorouracil—head and neck cancer	0.000424	0.00133	CcSEcCtD
Clomipramine—Hypotension—Docetaxel—head and neck cancer	0.000418	0.00131	CcSEcCtD
Clomipramine—GSTP1—thyroid gland—head and neck cancer	0.000411	0.0212	CbGeAlD
Clomipramine—Dizziness—Fluorouracil—head and neck cancer	0.00041	0.00129	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000408	0.00128	CcSEcCtD
Clomipramine—Insomnia—Docetaxel—head and neck cancer	0.000405	0.00127	CcSEcCtD
Clomipramine—Paraesthesia—Docetaxel—head and neck cancer	0.000402	0.00126	CcSEcCtD
Clomipramine—Dyspnoea—Docetaxel—head and neck cancer	0.000399	0.00125	CcSEcCtD
Clomipramine—Somnolence—Docetaxel—head and neck cancer	0.000398	0.00125	CcSEcCtD
Clomipramine—Vomiting—Fluorouracil—head and neck cancer	0.000394	0.00124	CcSEcCtD
Clomipramine—Dyspepsia—Docetaxel—head and neck cancer	0.000394	0.00124	CcSEcCtD
Clomipramine—Rash—Fluorouracil—head and neck cancer	0.000391	0.00123	CcSEcCtD
Clomipramine—Dermatitis—Fluorouracil—head and neck cancer	0.00039	0.00123	CcSEcCtD
Clomipramine—Decreased appetite—Docetaxel—head and neck cancer	0.000389	0.00122	CcSEcCtD
Clomipramine—Headache—Fluorouracil—head and neck cancer	0.000388	0.00122	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000386	0.00121	CcSEcCtD
Clomipramine—Fatigue—Docetaxel—head and neck cancer	0.000386	0.00121	CcSEcCtD
Clomipramine—Pain—Docetaxel—head and neck cancer	0.000383	0.0012	CcSEcCtD
Clomipramine—Constipation—Docetaxel—head and neck cancer	0.000383	0.0012	CcSEcCtD
Clomipramine—HTR2A—neck—head and neck cancer	0.00038	0.0196	CbGeAlD
Clomipramine—Feeling abnormal—Docetaxel—head and neck cancer	0.000369	0.00116	CcSEcCtD
Clomipramine—Nausea—Fluorouracil—head and neck cancer	0.000368	0.00116	CcSEcCtD
Clomipramine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000366	0.00115	CcSEcCtD
Clomipramine—GSTP1—head—head and neck cancer	0.000364	0.0188	CbGeAlD
Clomipramine—HRH2—lymph node—head and neck cancer	0.000354	0.0183	CbGeAlD
Clomipramine—Body temperature increased—Docetaxel—head and neck cancer	0.000354	0.00111	CcSEcCtD
Clomipramine—Abdominal pain—Docetaxel—head and neck cancer	0.000354	0.00111	CcSEcCtD
Clomipramine—HTR2B—thyroid gland—head and neck cancer	0.000339	0.0175	CbGeAlD
Clomipramine—Hypersensitivity—Docetaxel—head and neck cancer	0.00033	0.00104	CcSEcCtD
Clomipramine—Asthenia—Docetaxel—head and neck cancer	0.000321	0.00101	CcSEcCtD
Clomipramine—ADRA2A—connective tissue—head and neck cancer	0.00032	0.0165	CbGeAlD
Clomipramine—HTR2C—head—head and neck cancer	0.00032	0.0165	CbGeAlD
Clomipramine—Pruritus—Docetaxel—head and neck cancer	0.000317	0.000994	CcSEcCtD
Clomipramine—Diarrhoea—Docetaxel—head and neck cancer	0.000306	0.000962	CcSEcCtD
Clomipramine—SLC6A4—head—head and neck cancer	0.000303	0.0157	CbGeAlD
Clomipramine—HTR2B—head—head and neck cancer	0.0003	0.0155	CbGeAlD
Clomipramine—Dizziness—Docetaxel—head and neck cancer	0.000296	0.000929	CcSEcCtD
Clomipramine—Vomiting—Docetaxel—head and neck cancer	0.000284	0.000894	CcSEcCtD
Clomipramine—Rash—Docetaxel—head and neck cancer	0.000282	0.000886	CcSEcCtD
Clomipramine—Dermatitis—Docetaxel—head and neck cancer	0.000282	0.000885	CcSEcCtD
Clomipramine—Headache—Docetaxel—head and neck cancer	0.00028	0.000881	CcSEcCtD
Clomipramine—HTR2A—connective tissue—head and neck cancer	0.000272	0.0141	CbGeAlD
Clomipramine—ADRA2A—trachea—head and neck cancer	0.000269	0.0139	CbGeAlD
Clomipramine—SLC6A2—head—head and neck cancer	0.000267	0.0138	CbGeAlD
Clomipramine—Nausea—Docetaxel—head and neck cancer	0.000266	0.000835	CcSEcCtD
Clomipramine—HTR2A—epithelium—head and neck cancer	0.000259	0.0133	CbGeAlD
Clomipramine—GSTP1—lymph node—head and neck cancer	0.000255	0.0132	CbGeAlD
Clomipramine—CYP1A2—thyroid gland—head and neck cancer	0.000231	0.0119	CbGeAlD
Clomipramine—HTR2A—trachea—head and neck cancer	0.000229	0.0118	CbGeAlD
Clomipramine—ALB—lymph node—head and neck cancer	0.000219	0.0113	CbGeAlD
Clomipramine—ADRA2A—thyroid gland—head and neck cancer	0.000213	0.011	CbGeAlD
Clomipramine—HTR2B—lymph node—head and neck cancer	0.00021	0.0109	CbGeAlD
Clomipramine—ADRA2A—head—head and neck cancer	0.000189	0.00974	CbGeAlD
Clomipramine—SLC6A2—lymph node—head and neck cancer	0.000187	0.00965	CbGeAlD
Clomipramine—ABCB1—epithelium—head and neck cancer	0.000169	0.00875	CbGeAlD
Clomipramine—HTR2A—head—head and neck cancer	0.00016	0.00828	CbGeAlD
Clomipramine—ABCB1—trachea—head and neck cancer	0.00015	0.00774	CbGeAlD
Clomipramine—CYP2D6—head—head and neck cancer	0.000146	0.00755	CbGeAlD
Clomipramine—ADRA2A—lymph node—head and neck cancer	0.000132	0.00682	CbGeAlD
Clomipramine—ABCB1—lymphoid tissue—head and neck cancer	0.00013	0.00674	CbGeAlD
Clomipramine—ABCB1—thyroid gland—head and neck cancer	0.000119	0.00612	CbGeAlD
Clomipramine—ABCB1—head—head and neck cancer	0.000105	0.00543	CbGeAlD
Clomipramine—ABCB1—lymph node—head and neck cancer	7.36e-05	0.0038	CbGeAlD
Clomipramine—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	4.93e-05	0.000487	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.92e-05	0.000486	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.85e-05	0.000479	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.85e-05	0.000479	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PTEN—head and neck cancer	4.82e-05	0.000476	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NAT2—head and neck cancer	4.68e-05	0.000463	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NOTCH1—head and neck cancer	4.65e-05	0.000459	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—YAP1—head and neck cancer	4.6e-05	0.000454	CbGpPWpGaD
Clomipramine—ALB—Metabolism—DPYD—head and neck cancer	4.57e-05	0.000452	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NAT2—head and neck cancer	4.57e-05	0.000452	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—IL2—head and neck cancer	4.57e-05	0.000452	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	4.43e-05	0.000437	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—MAPK3—head and neck cancer	4.35e-05	0.00043	CbGpPWpGaD
Clomipramine—ALB—Metabolism—YAP1—head and neck cancer	4.34e-05	0.000429	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NAT2—head and neck cancer	4.31e-05	0.000426	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	4.28e-05	0.000422	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.21e-05	0.000416	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—IL2—head and neck cancer	4.21e-05	0.000416	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—IL2—head and neck cancer	4.17e-05	0.000412	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL2—head and neck cancer	4.15e-05	0.00041	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—MAPK1—head and neck cancer	4.14e-05	0.000409	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—EGFR—head and neck cancer	4.14e-05	0.000409	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—DPYD—head and neck cancer	4.11e-05	0.000406	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.07e-05	0.000402	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—DPYD—head and neck cancer	4.01e-05	0.000396	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—PIK3CA—head and neck cancer	3.96e-05	0.000391	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—YAP1—head and neck cancer	3.9e-05	0.000385	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.88e-05	0.000383	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.84e-05	0.000379	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—YAP1—head and neck cancer	3.8e-05	0.000376	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL2—head and neck cancer	3.79e-05	0.000374	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—DPYD—head and neck cancer	3.78e-05	0.000373	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NAT2—head and neck cancer	3.65e-05	0.00036	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—PIK3CA—head and neck cancer	3.59e-05	0.000355	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—YAP1—head and neck cancer	3.58e-05	0.000354	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—VEGFA—head and neck cancer	3.58e-05	0.000353	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NOTCH1—head and neck cancer	3.56e-05	0.000352	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	3.49e-05	0.000345	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.44e-05	0.00034	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PIK3CA—head and neck cancer	3.4e-05	0.000336	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—MAPK3—head and neck cancer	3.38e-05	0.000334	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—IL2—head and neck cancer	3.37e-05	0.000333	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—MAPK3—head and neck cancer	3.34e-05	0.00033	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HRAS—head and neck cancer	3.32e-05	0.000328	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IL2—head and neck cancer	3.32e-05	0.000328	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—TYMS—head and neck cancer	3.3e-05	0.000326	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GSTM1—head and neck cancer	3.26e-05	0.000323	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.26e-05	0.000322	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NOTCH1—head and neck cancer	3.25e-05	0.000321	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AKT1—head and neck cancer	3.23e-05	0.000319	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—MAPK1—head and neck cancer	3.22e-05	0.000318	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—DPYD—head and neck cancer	3.2e-05	0.000316	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL2—head and neck cancer	3.2e-05	0.000316	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—MAPK1—head and neck cancer	3.17e-05	0.000314	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—EGFR—head and neck cancer	3.17e-05	0.000314	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GPX1—head and neck cancer	3.13e-05	0.000309	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CCND1—head and neck cancer	3.12e-05	0.000308	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP1A1—head and neck cancer	3.09e-05	0.000306	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL2—head and neck cancer	3.06e-05	0.000302	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—MAPK3—head and neck cancer	3.05e-05	0.000301	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—YAP1—head and neck cancer	3.04e-05	0.0003	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—PIK3CA—head and neck cancer	3.03e-05	0.0003	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PTEN—head and neck cancer	3.01e-05	0.000297	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AKT1—head and neck cancer	2.93e-05	0.00029	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.93e-05	0.000289	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—IL2—head and neck cancer	2.92e-05	0.000289	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—MAPK1—head and neck cancer	2.9e-05	0.000286	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—EGFR—head and neck cancer	2.9e-05	0.000286	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.84e-05	0.000281	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VEGFA—head and neck cancer	2.82e-05	0.000279	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NAT2—head and neck cancer	2.82e-05	0.000278	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—PIK3CA—head and neck cancer	2.79e-05	0.000276	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—AKT1—head and neck cancer	2.78e-05	0.000274	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—PIK3CA—head and neck cancer	2.77e-05	0.000274	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—PIK3CA—head and neck cancer	2.75e-05	0.000272	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VEGFA—head and neck cancer	2.72e-05	0.000268	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—head and neck cancer	2.7e-05	0.000267	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—STAT3—head and neck cancer	2.69e-05	0.000266	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—MAPK3—head and neck cancer	2.67e-05	0.000264	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—IL2—head and neck cancer	2.66e-05	0.000263	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL2—head and neck cancer	2.65e-05	0.000262	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NOTCH1—head and neck cancer	2.62e-05	0.000259	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TYMS—head and neck cancer	2.61e-05	0.000258	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—HRAS—head and neck cancer	2.58e-05	0.000255	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTM1—head and neck cancer	2.58e-05	0.000255	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MAPK3—head and neck cancer	2.57e-05	0.000254	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.55e-05	0.000252	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HRAS—head and neck cancer	2.55e-05	0.000252	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—MAPK1—head and neck cancer	2.54e-05	0.000251	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—PIK3CA—head and neck cancer	2.51e-05	0.000248	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AKT1—head and neck cancer	2.48e-05	0.000245	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—DPYD—head and neck cancer	2.47e-05	0.000244	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GPX1—head and neck cancer	2.47e-05	0.000244	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MAPK3—head and neck cancer	2.46e-05	0.000243	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL2—head and neck cancer	2.45e-05	0.000242	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MAPK1—head and neck cancer	2.45e-05	0.000242	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EGFR—head and neck cancer	2.44e-05	0.000242	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP1A1—head and neck cancer	2.44e-05	0.000241	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL2—head and neck cancer	2.41e-05	0.000239	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCND1—head and neck cancer	2.39e-05	0.000236	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—YAP1—head and neck cancer	2.34e-05	0.000231	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TYMS—head and neck cancer	2.34e-05	0.000231	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MAPK1—head and neck cancer	2.34e-05	0.000231	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—EGFR—head and neck cancer	2.34e-05	0.000231	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HRAS—head and neck cancer	2.33e-05	0.00023	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.31e-05	0.000229	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PTEN—head and neck cancer	2.31e-05	0.000228	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TYMS—head and neck cancer	2.28e-05	0.000226	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—AKT1—head and neck cancer	2.28e-05	0.000225	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.28e-05	0.000225	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NOTCH1—head and neck cancer	2.28e-05	0.000225	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AKT1—head and neck cancer	2.26e-05	0.000223	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTM1—head and neck cancer	2.26e-05	0.000223	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AKT1—head and neck cancer	2.25e-05	0.000222	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL2—head and neck cancer	2.24e-05	0.000221	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	2.23e-05	0.000221	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GPX1—head and neck cancer	2.21e-05	0.000219	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PIK3CA—head and neck cancer	2.2e-05	0.000218	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.19e-05	0.000217	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCND1—head and neck cancer	2.18e-05	0.000216	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GPX1—head and neck cancer	2.16e-05	0.000214	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TYMS—head and neck cancer	2.15e-05	0.000213	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.14e-05	0.000211	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	2.13e-05	0.000211	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—head and neck cancer	2.13e-05	0.000211	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.13e-05	0.00021	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PIK3CA—head and neck cancer	2.12e-05	0.00021	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTEN—head and neck cancer	2.11e-05	0.000208	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—head and neck cancer	2.08e-05	0.000206	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	2.07e-05	0.000205	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—STAT3—head and neck cancer	2.06e-05	0.000204	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—head and neck cancer	2.05e-05	0.000203	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—head and neck cancer	2.05e-05	0.000203	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HRAS—head and neck cancer	2.04e-05	0.000201	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GPX1—head and neck cancer	2.04e-05	0.000201	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	2.03e-05	0.000201	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	2.03e-05	0.000201	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	2.03e-05	0.0002	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.02e-05	0.000199	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.01e-05	0.000198	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.99e-05	0.000197	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK3—head and neck cancer	1.97e-05	0.000195	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRAS—head and neck cancer	1.96e-05	0.000194	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	1.94e-05	0.000192	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.94e-05	0.000192	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	1.9e-05	0.000188	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—STAT3—head and neck cancer	1.88e-05	0.000186	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	1.88e-05	0.000185	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK1—head and neck cancer	1.88e-05	0.000185	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—head and neck cancer	1.88e-05	0.000185	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	1.85e-05	0.000182	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	1.85e-05	0.000182	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—head and neck cancer	1.84e-05	0.000182	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	1.83e-05	0.00018	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TYMS—head and neck cancer	1.82e-05	0.00018	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL2—head and neck cancer	1.81e-05	0.000178	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.8e-05	0.000178	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.8e-05	0.000178	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—head and neck cancer	1.8e-05	0.000178	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	1.8e-05	0.000178	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.76e-05	0.000174	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.76e-05	0.000174	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCND1—head and neck cancer	1.76e-05	0.000174	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—head and neck cancer	1.73e-05	0.000171	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPX1—head and neck cancer	1.73e-05	0.000171	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	1.71e-05	0.000169	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—head and neck cancer	1.71e-05	0.000169	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.71e-05	0.000169	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTEN—head and neck cancer	1.7e-05	0.000168	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	1.66e-05	0.000164	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	1.63e-05	0.000161	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PIK3CA—head and neck cancer	1.63e-05	0.000161	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTEN—head and neck cancer	1.61e-05	0.000159	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.6e-05	0.000158	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	1.58e-05	0.000157	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—head and neck cancer	1.57e-05	0.000156	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL2—head and neck cancer	1.57e-05	0.000155	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	1.53e-05	0.000152	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	1.53e-05	0.000151	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—STAT3—head and neck cancer	1.52e-05	0.00015	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRAS—head and neck cancer	1.51e-05	0.000149	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	1.49e-05	0.000147	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	1.48e-05	0.000146	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.48e-05	0.000146	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—head and neck cancer	1.45e-05	0.000144	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.45e-05	0.000143	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	1.44e-05	0.000142	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.44e-05	0.000142	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—head and neck cancer	1.44e-05	0.000142	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL2—head and neck cancer	1.43e-05	0.000141	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.41e-05	0.000139	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.4e-05	0.000139	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.39e-05	0.000137	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	1.39e-05	0.000137	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.38e-05	0.000136	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.38e-05	0.000136	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRAS—head and neck cancer	1.37e-05	0.000136	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	1.34e-05	0.000133	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.33e-05	0.000132	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.33e-05	0.000132	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—head and neck cancer	1.33e-05	0.000131	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.32e-05	0.00013	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.32e-05	0.00013	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	1.31e-05	0.000129	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.3e-05	0.000129	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—head and neck cancer	1.27e-05	0.000126	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTEN—head and neck cancer	1.27e-05	0.000125	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	1.26e-05	0.000125	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—head and neck cancer	1.21e-05	0.00012	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	1.21e-05	0.00012	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	1.2e-05	0.000119	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	1.2e-05	0.000118	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.2e-05	0.000118	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	1.2e-05	0.000118	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	1.2e-05	0.000118	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—head and neck cancer	1.16e-05	0.000115	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	1.15e-05	0.000113	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTEN—head and neck cancer	1.14e-05	0.000112	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CA—head and neck cancer	1.13e-05	0.000112	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTEN—head and neck cancer	1.11e-05	0.00011	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	1.11e-05	0.00011	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	1.09e-05	0.000108	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	1.09e-05	0.000108	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.05e-05	0.000103	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	1.04e-05	0.000103	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.02e-05	0.0001	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—head and neck cancer	1.01e-05	9.95e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	9.79e-06	9.67e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	9.63e-06	9.51e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	9.47e-06	9.35e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—head and neck cancer	9.25e-06	9.14e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—head and neck cancer	9.16e-06	9.05e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CA—head and neck cancer	8.94e-06	8.83e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTEN—head and neck cancer	8.86e-06	8.75e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	8.76e-06	8.65e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	8.5e-06	8.4e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	8.02e-06	7.93e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.84e-06	7.75e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CA—head and neck cancer	7.83e-06	7.74e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	7.73e-06	7.64e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	7.38e-06	7.29e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—head and neck cancer	7.3e-06	7.21e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTEN—head and neck cancer	6.84e-06	6.76e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—head and neck cancer	6.55e-06	6.47e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—head and neck cancer	6.4e-06	6.32e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	6.25e-06	6.18e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—head and neck cancer	6.03e-06	5.95e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—head and neck cancer	5.11e-06	5.04e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.82e-06	4.77e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—head and neck cancer	3.94e-06	3.89e-05	CbGpPWpGaD
